Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Echinococcus granulosus | hexokinase type 2 | 0.0084 | 0.3471 | 0.2841 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0068 | 0.2488 | 0.2461 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0041 | 0.088 | 0.088 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0035 | 0.0035 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0043 | 0.0043 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.088 | 0.0848 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0067 | 0.2449 | 0.5 |
Plasmodium falciparum | hexokinase | 0.0084 | 0.3471 | 0.3448 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0067 | 0.2449 | 0.172 |
Brugia malayi | hexokinase type II | 0.0027 | 0.0043 | 0.0043 |
Toxoplasma gondii | hexokinase | 0.0084 | 0.3471 | 0.3448 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.1591 | 0.1591 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Echinococcus granulosus | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Leishmania major | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0043 | 0.0043 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0067 | 0.2449 | 0.2422 |
Echinococcus multilocularis | hexokinase type 2 | 0.0084 | 0.3471 | 0.2841 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0194 | 1 | 1 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0124 | 0.0089 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0595 | 0.0595 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0194 | 1 | 1 |
Leishmania major | trypanothione reductase | 0.0194 | 1 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0084 | 0.3471 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Loa Loa (eye worm) | glutathione reductase | 0.0194 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0035 | 0.0035 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 0.2422 |
Leishmania major | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Echinococcus granulosus | geminin | 0.0179 | 0.9138 | 0.9055 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.088 | 0.0848 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma brucei | hexokinase | 0.0084 | 0.3471 | 0.3448 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0067 | 0.2449 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0067 | 0.2449 | 1 |
Brugia malayi | Hexokinase family protein | 0.0084 | 0.3471 | 0.3471 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.1591 | 0.1591 |
Onchocerca volvulus | 0.0084 | 0.3471 | 1 | |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0194 | 1 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0068 | 0.2488 | 0.2461 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0067 | 0.2449 | 0.172 |
Schistosoma mansoni | DNA polymerase eta | 0.0068 | 0.2488 | 0.2012 |
Echinococcus multilocularis | geminin | 0.0179 | 0.9138 | 0.9055 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0067 | 0.2449 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.2488 | 0.2488 |
Plasmodium vivax | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Onchocerca volvulus | 0.0084 | 0.3471 | 1 | |
Trypanosoma brucei | hexokinase | 0.0084 | 0.3471 | 0.3448 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 0.2422 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0067 | 0.2449 | 0.5 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0067 | 0.2449 | 0.2422 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0041 | 0.088 | 0.088 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0067 | 0.2449 | 1 |
Brugia malayi | Hexokinase family protein | 0.0053 | 0.1598 | 0.1598 |
Plasmodium falciparum | thioredoxin reductase | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Schistosoma mansoni | hexokinase | 0.0084 | 0.3471 | 0.3058 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1873 | 0.1873 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 1 |
Echinococcus granulosus | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Brugia malayi | hexokinase | 0.0084 | 0.3471 | 0.3471 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Loa Loa (eye worm) | hexokinase | 0.0053 | 0.1598 | 0.1598 |
Trypanosoma brucei | trypanothione reductase | 0.0194 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0068 | 0.2488 | 0.2488 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0067 | 0.2449 | 0.2422 |
Echinococcus granulosus | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Echinococcus multilocularis | dna polymerase eta | 0.0068 | 0.2488 | 0.1763 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Loa Loa (eye worm) | hexokinase | 0.0084 | 0.3471 | 0.3471 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0595 | 0.0595 |
Onchocerca volvulus | 0.0084 | 0.3471 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.9138 | 0.9083 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0049 | 0.1386 | 0.1386 |
Plasmodium falciparum | glutathione reductase | 0.0067 | 0.2449 | 0.2422 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0067 | 0.2449 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0124 | 0.0089 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1591 | 0.1591 |
Toxoplasma gondii | thioredoxin reductase | 0.0194 | 1 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0067 | 0.2449 | 0.172 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0067 | 0.2449 | 0.2449 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.004 | 0.0808 | 0.0776 |
Plasmodium vivax | glutathione reductase, putative | 0.0194 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0194 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0194 | 1 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.004 | 0.0808 | 0.0776 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0067 | 0.2449 | 0.172 |
Trypanosoma brucei | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Leishmania major | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 0.1971 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0124 | 0.0089 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0067 | 0.2449 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.1591 | 0.1591 |
Loa Loa (eye worm) | hexokinase type II | 0.0084 | 0.3471 | 0.3471 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0067 | 0.2449 | 0.2422 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2449 | 0.2422 |
Plasmodium falciparum | glutathione reductase | 0.0194 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0124 | 0.0089 |
Echinococcus multilocularis | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Echinococcus multilocularis | hexokinase | 0.0084 | 0.3471 | 0.2841 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0041 | 0.088 | 0.0303 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0067 | 0.2449 | 0.2422 |
Entamoeba histolytica | hexokinase 1 | 0.0084 | 0.3471 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.9138 | 0.9083 |
Echinococcus granulosus | dna polymerase eta | 0.0068 | 0.2488 | 0.1763 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Loa Loa (eye worm) | hexokinase | 0.0084 | 0.3471 | 0.3471 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0041 | 0.088 | 0.0303 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Treponema pallidum | hexokinase (hxk) | 0.0084 | 0.3471 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0194 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma brucei | unspecified product | 0.0041 | 0.088 | 0.0848 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 0.172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0067 | 0.2449 | 0.2422 |
Brugia malayi | Thioredoxin reductase | 0.0194 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.004 | 0.0808 | 0.0776 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0124 | 0.0089 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0049 | 0.1386 | 0.1386 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.088 | 0.0848 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0067 | 0.2449 | 0.172 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0067 | 0.2449 | 0.2422 |
Trypanosoma cruzi | hexokinase, putative | 0.0084 | 0.3471 | 0.3448 |
Plasmodium falciparum | thioredoxin reductase | 0.0194 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0067 | 0.2449 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.088 | 0.0848 |
Leishmania major | DNA polymerase eta, putative | 0.0068 | 0.2488 | 0.2461 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 75 uM | Inhibition of ADP-induced human platelet aggregation. | ChEMBL. | 1404230 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.